Carotenoids: 2. Diseases and supplementations studies;Les carotenoides: 2. Pathologie et etudes de supplementation

Annales de Biologie Clinique

Volumn 57, Issue 3, 1999, Pages 273-282

  Faure, H ^f   Fayol, V ^a   Galabert, C ^b   Grolier, P ^c   Le Moel G ^d   Steghens, J P ^e   Nabet, F ^f  

^a LMM Laboratoire Marcel Merieux   (France)

^b Hopital Renee Sabran   (France)

^c CEMAGREF   (France)

^d BICHAT HOSPITAL   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f NONE

Author keywords

Carotenoids in cancer; Carotenoids in cardiovascular diseases; Supplementation; Toxicity

Indexed keywords

ALPHA TOCOPHEROL; ASBESTOS; BETA CAROTENE; CAROTENOID; CIGARETTE SMOKE; SELENIUM; ZINC; ANTINEOPLASTIC AGENT;

CANCER; CARDIOVASCULAR DISEASE; CHINA; CORRELATION FUNCTION; DIET SUPPLEMENTATION; DIETARY INTAKE; FRUIT; HUMAN; LUNG CANCER; MORTALITY; NUTRITIONAL STATUS; REVIEW; RURAL POPULATION; STOMACH CANCER; VEGETABLE; VITAMIN BLOOD LEVEL; BLOOD; NEOPLASM; RETINA DISEASE; SKIN DISEASE;

ANTICARCINOGENIC AGENTS; CARDIOVASCULAR DISEASES; CAROTENOIDS; CHINA; DIETARY SUPPLEMENTS; HUMANS; NEOPLASMS; RETINAL DISEASES; SKIN DISEASES; VITAMIN E;

EID: 0033127226     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Faure H, Fayol V, Galabert C, et al. Caroténoïdes : I - Métabolisme et physiologie. Ann Biol Clin 1999 ; 57 : 169-83.
2. Gridley G, McLaughlin JK, Block G, et al. Diet and oral and pharyngeal cancer among blacks. Nuir Cancer 1990 ; 14 : 219-25.
3. Ziegler RG, Colavito EA, Hartge P, et al. Importance of alpha-carotene, beta-carotene and other phytochemicals in the etiology of lung cancer. J Natl Cancer Inst 1996 ; 88 : 612-5.
4. Ocke MC, Buenode Mesquita HB, et al. Repeated measurements of vegetables, fruits, beta-carotene, and vitamin C and E in relation to lung cancer. The Zutphen study. Am J Epidemiol 1997 ; 145 : 358-65.
5. Wu-Williams AH, Dai XD, Blot W, et al. Lung cancer among women in Northeast China. Br J Cancer 1990 ; 62 : 982-7.
6. Negri E, La Vecchia C, Granceschi S, Levi F, Parazzini F. Intake of selected micronutrients and the risk of endometrial carcinoma. Cancer 1996 ; 77 : 917-23.
7. Negri E, La Vecchia C, Franceschi S, et al. Intake of selected micronutrients and the risk of breast cancer. Int J Cancer 1996 ; 65 : 140-4.
8. Zheng W, Sellers TA, Doyle TJ, Kushi LH, Potter JD, Folsom AR. Retinol antioxidant vitamins and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women. Am J Epidemiol 1995 ; 142 : 955-60.
9. Knekt P, Jarveinen R, Seppanen R, et al. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol 1991 ; 134 : 471-9.
10. Le Marchand L, Hankin JH, Kolonel LN, Beecher GR, Wilkens LR, Zhao LP. Intake of specific carotenoids and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1993 ; 2 : 183-7.
11. Franceschi S, Bidoli E, La Vecchia C, Talamini R, d'Avanzo B, Negri E. Tomatoes and risk of digestive tract cancers. Int J Cancer 1994 ; 59 : 181-4.
12. Giovannucci E, Ascherio A, Rimm EB, Stampfer MF, Colditz GA, Willet WC. Intake of carotenoïds and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995 ; 87 : 1767-76.
13. Martini MC, Campbell DR, Gross MD, Grandits GA, Potter JD, Slavin JL. Plasma carotenoïds as biomarkers of vegetable intake. Cancer Epidemiol Biomarkers Prev 1995 ; 4 : 491-6.
14. Batieha AM, Armenian HK, Norkus EP, Morris JS, Spat VE, Comstock GW. Serum micronutrients and the subsequent risk of cervical cancer in a population based nested case control study. Cancer Epidemiol Biomarkers Prev 1993 ; 2 : 335-9.
15. Le Gardeur BY, Lopez SA, Johnson WD. A case control study of serum vitamins A, E and C in lung cancer patients. Nutr Cancer 1990 ; 14 : 133-40.
16. Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW. Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 1996 ; 88 : 32-7.
17. Eichholzer M. Stähelin HB, Gey KF, Ludin E, Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins : 17 year follow-up of the prospective based study. Int J Cancer 1996 ; 66 : 145-50.
18. Stryker WS, Stampfer MJ, Stein EA, et al. Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol 1990 ; 131 : 597-611.
19. Breslow RA, Alberg AJ, Helzlsouer KJ, et al. Serological precursors of cancer-malignant-melanoma, basal and squamous cell skin-cancer, and prediagnostic levels of retinol, beta-carotene, lycopene, alpha-tocopherol and selenium. Cancer Epidemiol Biomarkers Prev 1995 ; 8 : 837-42.
20. Burney PG, Comstock GW, Morris JS. Serologic precursors of cancer : serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 1989 ; 49 : 895-900.
21. Potischman N, McCulloch CE, Byers T, et al. Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am J Clin Nutr 1990 ; 52 : 909-15.
22. Potischman N, Herrero R, Brinton LA. A case-control study of nutrients status and invasive cervical cancer. Am J Epidemiol 1991 ; 134 : 1343-55.
23. Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intakes and coronary mortality in a longitudinal population study. Am J Epidemiol 1994 ; 139 : 1180-9.
24. Lindeberg S, Vessby B. Fatty acid composition of cholesterol esters and serum tocopherols in Melanesians apparently free from cardiovascular disease. The Kitava study. Nut Metab Cardio Vasc Dis 1995 ; 5 : 45-53.
25. Sanderson KJ, van Ry AM, Wade CR, Sutherland WHF. Lipid peroxidation of circulating low-density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis 1995 ; 118 : 45-51.
26. Kardinal AFM, Aro A, Karls JD, et al. Association between β carotene and acute myocardial infarction depends on polyunsaturated fatty acid status. The euramic study. Arteroscler Thromb Vasc Biol 1995 ; 15 : 726-32.
27. Woodall AA, Britton G, Jackson MJ. Carotenoids and protection of phospholipids in solution or in liposome against oxidation by peroxyl radicals : relationship between carotenoid structure and protective ability. Biochim Biophys Acta 1997 ; 1336 : 575-86.
28. Kalyanaraman B, Darley-Usmar U, Struck A, Hogg N, Parthasarathy S. Role of apolipoprotein B derived radical and alpha-tocopheroxyl radical in peroxidase dependant oxidation of low density lipoprotein. J Lip Res 1995 ; 36 : 1037-45.
29. Garner B, Jessup W. Cell-mediated oxidation of low-density lipoprotein : the elusive mechanism(s). Redox Report 1996 ; 2 : 97-104.
30. Demuth K, Myara I, Moatti N. Biologie de la cellule endothéliale et athérogenèse. Ann Biol Clin 1995 ; 53 : 171-89.
31. Nagano Y, Arai H, Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 1991 ; 88 : 6457-61.
32. Keaney JF, Vita JA. Atherosclerosis oxidative stress and antioxidant protection in endothelium derived relaxing factor action. Prog Cardiovasc Dis 1995 ; 38 : 129-54.
33. Levy Y, Kaplan M, Ben Amatz A, Aviram M. Effects of dietary supplementation of β carotene on human monocyte macrophage mediated oxidation of low density lipoprotein. Int J Med Sci 1996 ; 32 : 473-8.
34. Gaziano JM, Hennekens CH. Antioxidant vitamins in the prevention of coronary artery disease. Cont Int Med 1995 ; 7 : 9-14.
35. Omenn GS, Goodman GE, Thomquist MD, et al. Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996 ; 334 : 1150-5.
36. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with β carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996 ; 334 : 1145-9.
37. Jha P, Flather M, Lonn E, Farkouk M, Yusuf S. The oxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995 ; 123 : 860-72.
38. Thurnham DI. Carotenoids : functions and fallacies. Proc Nutr Soc 1994 ; 53 : 77-87.
39. Khachik F, Berstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. J Invest Ophtalmol VIS Sci 1997 ; 9 : 1802-11.
40. Tavani A, Negri E, Lareccha C. Food and nutrient intake in risk of cataract. Ann Epidemiol 1996 ; 6 : 41-6.
41. Age-related macular degeneration study group. Multicenter ophthamic and nutritional age-related macular degeneration study. Part 2. Antioxidant intervention and conclusions. J Am Ophtamol Assoc 1996 ; 67 : 40-9.
42. Mares-Perlman JA, Brad WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population based case-control study. Arch Ophtalmol 1995 ; 113 : 1518-23.
43. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998 ; 67 : 143-7.
44. Omene JA, Easington CR, Glew RH, Prosper M, Ledlie S. Serum beta-carotene deficiency in HIV-infected children. JAMA 1996 ; 88 : 789-93.
45. Phuapradit W, Chaturachinda K, Taneepanichskul S, Sirivarasry J, Khupulsup K, Lerdvuthisopon N. Serum vitamin A and beta-carotene levels in pregnant women infected with human immunodeficiency virus-1. Obst Gynecol 1996 ; 87 : 564-7.
46. Fryburg DA, Mark RJ, Griffith BP, Askenase PW, Patterson TF. The effect of supplemental beta-carotene on immunological indexes in patients with Aids. A pilot study. Yale J Biol Med 1995 ; 68 : 19-23.
47. Rosman AS, Lieber CS. Differential depletion of carotenoids and tocopherol in liver-disease. Hepatology 1993 ; 17 : 977-86.
48. Ahmed S, Lee MA, Lieber CS. Interactions between alcohol and beta-carotene in patients with alcoholic liver-disease. Am J Clin Nutr 1994 ; 60 : 430-6.
49. Homnick DN, Cox JH, Deloof MJ, Ringer TV. Carotenoid levels in normal children and in children with cystic fibrosis. J Pediatr 1993 ; 122 : 703-7.
50. Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AE. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995 ; 61 : 843-7.
51. Van der Vliet A, Eiserich JP, Marelich GP, Halliwell B, Cross CE. Oxidative stress in cystic fibrosis : does it occur and does it matter? Adv Pharmacol 1997 ; 38 : 491-513.
52. Lepage G, Champagne J, Ronco N, et al. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1996 ; 64 : 87-93.
53. Mathews-Roth MM. Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity disease. Biochimie 1986 ; 68 : 875-84.
54. Naldi L, Parazzini F, Peli P, Chatenoud L, Camelli T, Rebora A. Dietary factors and the risk of psoriasis. Results of an italian case-control study. Br J Dermatol 1996 ; 1 : 101-6.
55. Golnick HPM, Hopfenmuller W, Hemmes C, et al. Systemic beta-carotene plus tropical UV-sunscreen are an optimal protection against harmful effects of natural UV-sunlignt : results of the Berlin-Eilath Study. Eur J Dermatol 1996 ; 6 : 200-7.
56. Comstock GW, Burke AE, Hoffman SC, et al. Serum concentrations of alpha-tocopherol, beta-carotene and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematous. Ann Rheum Dis 1997 ; 56 : 323-5.
57. Kreisch MJ, Fond AKH, Burri BJ, Jacob RA. Menstrual cycle abnormalities associated with low cartenoid diets. FASEB J 1995 ; 9 : A997.
58. Berg G, Kohlmeier L, Brenner H. Use of contraceptives and serum beta-carotene. Eur J Clin Nutr 1997 ; 51 : 181-87.
59. Zbinden G, Studer A. Tierexperimentelle untersuchungen über die chronische verträglichkeit von β carotin, lycopin, 7,7'-dihydro-β-carotin and bixin. Leb Untersuch Forsch 1958 ; 108 : 113-34.
60. FAO. Évalutation toxicologique de certains additifs alimentaires. Série réunion de la FAO sur la nutrition 1976 ; 54AZ.
61. Lyco Red. The Health benefits of natural phytoceuticals. Montréal, July 22-23, Proceedings 1997.
62. Heywood R, Palmer AK, Gregson RL, Hummler H. The toxicity of beta-carotene. Toxicology 1985 ; 36 : 91-100.
63. Ishidate M, Yoshikawa K. Chromosome aberration tests with Chinese hamster cells in vitro with and without metabolic activation. A comparative study on mutagens and carcinogens. Arch Toxicol 1980 ; 4 : 41-4.
64. Hallogan JB, Allen DC, Borzelleca JF. The safety and regulatory status of food, drug and cosmetics colour additives exempt from certification. Fd Chem Toxic 1995 ; 33 : 515-28.
65. Alam BS, Alam SQ, Weir JC, Gibson WA. Chemopreventive effects of β carotene and 13-cis-retinoic acid on salivary gland tumors. Nutr Cancer 1984 ; 6 : 4-12.
66. Takahashi O. Haemorrhagic toxicity of a large dose of α-, β-, γ-, δ-tocopherols ubiquinone, β-carotene, retinol acetate and L-ascorbic acid in the rat. Fd Chem Toxic 1995 ; 33 : 121-8.
67. Vakil DV, Ayiomamiris A, Nizami N, Nizami RM. Hypercarotene-mia : a case report and a review of the literature. Nutr Res 1985 ; 5 : 911-7.
68. Xu MJ, Plezia PM, Alberts DS, et al. Reduction in plasma or skin alpha-tocopherol concentration with long term oral administration of beta-carotene in human and mice. J Natl Cancer Inst 1992 ; 84 : 1559-65.
69. Morinobu T, Tamai H, Murata T, et al. Changes in β-carotene levels by long-term administration of natural β-carotene derived from Dunaliella Bardawil in humans. J Nutr Sci Vitaminol 1994 ; 40 : 421-30.
70. Cortin P, Boudreault G, Rousseau AP, Tardif Y, Malenfant M. La rétinopathie à la canthaxanthine. 1. Étude clinique de 51 consommateurs. Can J Ophtalmol 18 : 325-8.
71. Boudreault G, Cortin P, Corriveau LA, Rousseau AP, Tardif Y, Malenfant M. La rétinopathie à la canthaxanthine : 1. Étude clinique de 51 consommateurs. Can J Ophtalmol 18 : 325-8.
72. Buring JE, Hennekens CH. β carotene and cancer chemoprevention. J Cell Biochem 1995 ; (suppl. 22) : 226-30.
73. Van Poppel G. Epidemiological evidence for β carotene in prevention of cancer and cardiovascular disease. Eur J Clin Nutr 1996 ; 50 (suppl. 3) : S55-7.
74. Prabhat J, Flather M, Lunn E, Farkouk M, Yusuf S. The antioxidant vitamins and cardiovascular disease. Ann Intern Med 1995 ; 123 : 860-72.
75. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China : supplementation with specific vitamin/mineral combinations, cancer incidence and disease specific mortality in the general population. J Natl Cancer Inst 1993 ; 85 : 1483-92.
76. Greenberg ER, Baron JA, Stukel TA, et al. The skin cancer prevention study group. A clinical trial of β carotene to prevent basel-cell and squamous-cell cancers of the skin. N Engl J Med 1990 ; 323 : 789-95.
77. The alpha-tocopherol, β carotene cancer prevention study group. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994 ; 330 : 1029-35.